Primary Care Diabetes
Volume 1, Issue 1 , Pages 17-23 , February 2007

Quality indicators for type-2 diabetes care in practice guidelines: An example from six European countries

  • Johan Wens

      Affiliations

    • University of Antwerp, Faculty of Medicine, Department of General Practice, Integrated Health Care and Geriatrics, Universiteitsplein 1, 2610 Wilrijk, Antwerp, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32 3 820 25 29; fax: +32 3 820 25 26.
    • ,
  • Kristien Dirven

      Affiliations

    • University of Antwerp, Faculty of Medicine, Department of General Practice, Integrated Health Care and Geriatrics, Universiteitsplein 1, 2610 Wilrijk, Antwerp, Belgium
    • ,
  • Chantal Mathieu

      Affiliations

    • Catholic University of Leuven, Department Experimental Medicine—Endocrinology, Herestraat, 49 Box 902, 3000 Leuven, Belgium
    • Flemish Diabetes Association, Ottergemsesteenweg 456, 9000 Gent, Belgium
    • ,
  • Dominique Paulus

      Affiliations

    • Belgian Health Care Knowledge Centre, Résidence Palace Blok A, Wetstraat 155, 1040 Brussel, Belgium
    • ,
  • Paul Van Royen

      Affiliations

    • University of Antwerp, Faculty of Medicine, Department of General Practice, Integrated Health Care and Geriatrics, Universiteitsplein 1, 2610 Wilrijk, Antwerp, Belgium
    • ,
  • On behalf of the Belgian Diabetes Project Group

      Affiliations

    • See Acknowledgements.

Received 21 April 2006 ,Revised 2 June 2006 ,Accepted 14 July 2006.

References 

  1. IDF, Clinical Guidelines Task Force, Global Guideline for type 2 diabetes, Brussels, 2005.
  2. Amos A, McCarty D, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diab. Med. 1997;14(Suppl. 5):1–85
  3. Jeppesen P, Bek T. The occurrence and causes of registered blindness in diabetes patients in Århus County, Denmark. Acta Ophthalmol. Scand. 2004;82(5):526–530
  4. Chaturvedi N, Stevens LK, Fuller JH, Lee ET, Lu M. Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44:S65–S71
  5. Atkins R. The epidemiology of chronic kidney disease. Review. Kidney Int. Suppl. 2005;94(Apr):S14–S18
  6. American Diabetes Association . Standards of medical care in diabetes-2006. Diab. Care. 2006;29(Suppl. 1):S4–S42
  7. Field MJ, Lohr KN. Institute of medicine committee to advise the public health service on clinical practice guidelines. Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press; 1990;
  8. Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am. J. Med. 2005;118(3):276–284
  9. Smith S, Bury G, O’Leary M, Shannon W, Tynan A, Staines A, et al. The North Dublin randomized controlled trial of structured diabetes shared care. Fam. Pract. 2004;21(1):39–45
  10. de Fine Olivarius N, Beck-Nielsen H, Andreasen AH, Horder M, Pedersen PA. Randomized controlled trial of structured, individualized treatment of type 2 diabetes mellitus. The project of Diabetes Care in General Practice [Article in Danish]. Ugeskr Laeger. 2001 Oct 29;163(44):6134–6139
  11. Wens J, Vermeire E, Van Royen P, Sabbe B, Denekens J. GPs’ perspectives of type 2 diabetes patients’ adherence to treatment: a qualitative analysis of barriers and solutions. BMC Family Pract. 2005;6(1):20
  12. Griffin S, Kinmonth AL. Systems for routine surveillance for people with diabetes mellitus [Systematic Review]. Cochrane Database Syst. Rev. 2006;(1):
  13. Renders CM, Valk GD, Griffin S, Wagner EH, van Eijk JThM, Assendelft WJJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings [Systematic Review]. Cochrane Database Syst. Rev. 2006;(1):
  14. Ibrahim JE. Performance indicators from all perspectives. Int. J. Qual. Health Care. 2001;13(6):431–432
  15. Roski J, Gregory R. Performance measurement for ambulatory care: moving towards a new agenda. Int. J. Qual. Health Care. 2001;13(6):447–453
  16. McLoughlin V, Leatherman S, Fletcher M, Owen JW. Improving performance using indicators. Recent experiences in the United States, the United Kingdom, and Australia. Int. J. Qual. Health Care. 2001;13(6):455–462
  17. Scally G, Donaldson LJ. Looking forward: clinical governance and the drive for quality improvement in the new NHS in England. BMJ. 1998;317(7150):61–65
  18. The Diabetes Control and Complications Trial Research G . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993;329(14):977–986
  19. AGREE Collaboration . Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual. Saf. Health Care. 2003;12(1):18–23
  20. Marshall M, Roland M, Campbell S, Kirk S, Reeves D, Brook R, et al. Measuring general practice. A demonstration project to develop and test a set of primary care clinical quality indicators. Nuffield Trust. 2003;
  21. Donabedian A. The quality of care. How can it be assessed?. JAMA. 1988;260(12):1743–1748
  22. Mant J. Process versus outcome indicators in the assessment of quality of health care. Int. J. Qual. Health Care. 2001;13(6):475–480
  23. Marshall M, Shekelle P, McGlynn E, Campbell S, Brook R, Roland M. Can health care quality indicators be transferred between countries?. Qual. Saf. Health Care. 2003;12:8–12

PII: S1751-9918(06)00003-9

doi: 10.1016/j.pcd.2006.07.001

Primary Care Diabetes
Volume 1, Issue 1 , Pages 17-23 , February 2007

Article Tools